Stay updated with breaking news from Tech Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novozymes A/S (OTCPK:NVZMF) Q1 2022 Results Conference Call April 27, 2022 03:00 AM ET Company Participants Tobias Bjorklund - Head, IR Ester Baiget - CEO Lars Green - CFO Tina Fanoe - EVP,...
Novozymes is executing on its strategic framework by delivering 6% organic sales growth for 2021 and presenting a solid organic growth outlook of 3-7% for 2022. The company is also on track to meet its
Investegate announcements from Novozymes A/S, Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance
Novozymes delivered 7% organic sales growth in the third quarter and 6% organic sales growth in the first nine months of 2021. Due to stronger performance the company has upgraded its full-year financial
Novozymes A/S: Novozymes delivers solid Q1 results with 3% organic sales growth and strong earnings The company maintains its full-year financial guidance. COPENHAGEN, Denmark - April 27, 2021. With 3% organic sales growth in Q1, Novozymes is off to a good start to the year. Despite currency headwinds and negative M&A-related effects, Novozymes delivers an EBIT-margin of 29.6%. ROIC including goodwill was 23.4%. "I am very pleased with our first quarter results, and I am sincerely impressed by the organization's ability to rapidly adapt to changing conditions and be there to service our cus...